» Articles » PMID: 30674334

Baseline Differences in Characteristics and Risk Behaviors Among People Who Inject Drugs by Syringe Exchange Program Modality: an Analysis of the Miami IDEA Syringe Exchange

Overview
Journal Harm Reduct J
Publisher Biomed Central
Specialties Pharmacology
Psychiatry
Date 2019 Jan 25
PMID 30674334
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In March of 2016, Florida passed the Infection Disease Elimination Act (IDEA), legalizing the formation of the first syringe exchange program in Florida, which opened in December of 2016 at a fixed site in Overtown, Miami. Since that time, the exchange expanded in April of 2017 to include a mobile van unit that provides the same services at different locations throughout Miami-Dade County.

Methods: Trained interviewers conducted face-to-face interviews from all first-time participants at the IDEA Exchange, both at the fixed site and the mobile van unit.

Results: Among 718 first-time enrollees, 74.8% were male, 52.1% were non-Hispanic White, 85.9% completed high school, 59.8% were unemployed, 42.1% were homeless, 54.2% reported an annual income of less than $15,000, and the mean age was 38 years. Participants at the fixed site and mobile van unit reported differences in socioeconomic status, injection drug-related behaviors, and pre-existing hepatitis C virus (HCV) infection status.

Conclusions: Taken together, these results suggest that the mobile unit is capturing a subset of PWID in Miami that the fixed site is not, and vice-versa. As the opioid crisis extends into all demographics, such multimodal efforts to target various populations of PWID should be kept in mind, especially when unveiling future syringe exchanges in Florida and other late-adopting states.

Citing Articles

Reaching people who use drugs with sexual and reproductive healthcare through syringe services programs: potential promise and missed opportunities.

Scheidell J, Chueng T, Ciraldo K, Hervera B, Dakoulas S, Mahachi M Harm Reduct J. 2024; 21(1):198.

PMID: 39543633 PMC: 11566571. DOI: 10.1186/s12954-024-01116-5.


COVID-19 vaccine implementation at a syringe services program: experiences of frontline staff.

Plesons M, Soto Sugar S, Chimbaru R, McDonald G, Friedman L, Thompson Jr E BMC Health Serv Res. 2024; 24(1):1260.

PMID: 39427164 PMC: 11490171. DOI: 10.1186/s12913-024-11691-9.


An economic analysis of the cost of mobile units for harm reduction, naloxone distribution, and medications for opioid use disorder.

Castry M, Tin Y, Feder N, Lewis N, Chatterjee A, Rudorf M J Subst Use Addict Treat. 2024; 167:209517.

PMID: 39299504 PMC: 11527578. DOI: 10.1016/j.josat.2024.209517.


Delivering integrated strategies from a mobile unit to address the intertwining epidemics of HIV and addiction in people who inject drugs: the HPTN 094 randomized controlled trial protocol (the INTEGRA Study).

Goodman-Meza D, Shoptaw S, Hanscom B, Smith L, Andrew P, Kuo I Trials. 2024; 25(1):124.

PMID: 38360750 PMC: 10870682. DOI: 10.1186/s13063-023-07899-5.


Willingness to utilize a mobile treatment unit in five counties at the epicenter of the US rural opioid epidemic.

Peddireddy S, Livingston 3rd M, Young A, Freeman P, Ibragimov U, Komro K J Subst Use Addict Treat. 2023; 159:209262.

PMID: 38103835 PMC: 10947911. DOI: 10.1016/j.josat.2023.209262.


References
1.
Vlahov D, Junge B . The role of needle exchange programs in HIV prevention. Public Health Rep. 1998; 113 Suppl 1:75-80. PMC: 1307729. View

2.
Tookes H, Diaz C, Li H, Khalid R, Doblecki-Lewis S . A Cost Analysis of Hospitalizations for Infections Related to Injection Drug Use at a County Safety-Net Hospital in Miami, Florida. PLoS One. 2015; 10(6):e0129360. PMC: 4468183. DOI: 10.1371/journal.pone.0129360. View

3.
Guydish J, Bucardo J, Clark G, Bernheim S . Evaluating needle exchange: a description of client characteristics, health status, program utilization, and HIV risk behavior. Subst Use Misuse. 1998; 33(5):1173-96. DOI: 10.3109/10826089809062213. View

4.
Des Jarlais D, Friedman S . HIV epidemiology and interventions among injecting drug users. Int J STD AIDS. 1996; 7 Suppl 2:57-61. DOI: 10.1258/0956462961917654. View

5.
Compton W, Jones C, Baldwin G . Relationship between Nonmedical Prescription-Opioid Use and Heroin Use. N Engl J Med. 2016; 374(2):154-63. PMC: 11784537. DOI: 10.1056/NEJMra1508490. View